Hwail Pharmaceutical Co.,Ltd. (KOSDAQ:061250)
South Korea · Delayed Price · Currency is KRW 8,040.00
-90.00 (-1.11%)
At close: Sep 10, 2026
Hwail Pharmaceutical Market Cap
Hwail Pharmaceutical has a market cap or net worth of 66.47 billion as of September 11, 2026. Its market cap has decreased by -35.32% in one year.
Market Cap
66.47B
Enterprise Value
-23.12B
Revenue
107.87B
Ranking
n/a
PE Ratio
16.65
Stock Price
8,040.00
ChartMarket Cap Chart
Since March 3, 2003, Hwail Pharmaceutical's market cap has increased from 24.67B to 66.47B, an increase of 169.38%. That is a compound annual growth rate of 4.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 66.47B | -31.58% |
| Dec 30, 2025 | 97.15B | -6.85% |
| Dec 30, 2024 | 104.30B | -27.25% |
| Dec 28, 2023 | 143.36B | -22.49% |
| Dec 29, 2022 | 184.96B | 7.56% |
| Dec 30, 2021 | 171.96B | -31.70% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sam-A Pharm. | 85.14B |
| KOREA PHARMA | 83.11B |
| Samik Pharmaceutical Company LTD. | 79.63B |
| Daehan Nupharm | 78.46B |
| BL Pharmtech | 75.91B |
| GL Pharm Tech | 72.59B |
| Polaris AI Pharma | 72.53B |
| Pharos iBio | 71.85B |